Merck | Home
WEBAt Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Merck & Co. - Wikipedia
WEBMerck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of which it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada.
Discover Job Opportunities at Merck | Merck Careers
WEBExplore current job opportunities at Merck. Learn more about careers in Business Support, Clinical, Engineering, Information Technology, Research & Development, Manufacturing and Marketing.
Merck - The Vibrant Science & Technology Company
WEBAt Merck we translate science and technology into internal innovation and external partnerships that have the power to changes lives. Now more than ever, we’re keeping digitalization at the forefront of it all.
Merck Group - Wikipedia
WEBThe Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany.
Who we are - Merck.com
WEBWe aspire to be the premier research-intensive biopharmaceutical company. We’re at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals.
We are Merck
WEBBrilliant ideas are born at Merck. Our advanced treatment solutions and innovative technology are life-changing, influencing how we tackle major illnesses and integral to creating a better tomorrow. From cancer therapies and laboratory tools to smartphones, science and technology touch our lives.
Company fact sheet - Merck.com
WEBDec 31, 2023 · Merck is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products. View the list of products marketed in the U.S.
Investor relations - Merck.com
WEB6 days ago · Investor relations. Our science-led strategy is key to delivering long-term value for patients, employees and shareholders. View stock information.
KEYTRUDA® (pembrolizumab) Plus Chemotherapy Before Surgery and ... - Merck
WEB6 days ago · RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first-time presentation of overall survival (OS) results from the Phase 3 KEYNOTE-522 trial evaluating KEYTRUDA ® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination with chemotherapy as pre-operative (neoadjuvant) treatment and then continuing as a single ...
Skip to content